Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review

@article{Svensk2008CannabinoidR1,
  title={Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review},
  author={Ivana Hradilov{\'a} Sv{\'i}{\vz}ensk{\'a} and Petr Dubov{\'y} and Alexandra {\vS}ulcov{\'a}},
  journal={Pharmacology Biochemistry and Behavior},
  year={2008},
  volume={90},
  pages={501-511}
}

Tables from this paper

Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's disease and Less Well-Known Diseases.
TLDR
The current knowledge of the therapeutic potential of cannabinoid receptor as a target in Alzheimer's disease and other less well-known diseases that include, among others, multiple sclerosis, bone metabolism, and Fragile X syndrome is reviewed.
An in Vitro investigation of the effects of Rimonabant (a cannabinoid CB1 receptor antagonist) on cell adhesion and inflammatory associated cytokine production
TLDR
The main aim of this study is to investigate the in vitro effects of Rimonabant alone and in combination with anandamide on inflammatory associated cytokine production by human umbilical vein endothelial cells (HUVEC) and macrophage cultures.
Medical Use of Cannabinoids
TLDR
There is evidence for a role of the endocannabinoid system in the control of emotional states, and cannabinoids could prove useful in decreasing and palliating post-traumatic stress disorder symptoms and anxiolytic disorders.
Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions.
TLDR
The main properties of cannabinoids in cell death are described and attempts to clarify the different pathways triggered by these compounds that may help to understand the complexity of respective molecular mechanisms and explore the potential clinical benefit of cannabinoids use in cancer therapies.
Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases
  • Contino M
  • Biology, Medicine
    Open Access Journal of Pharmaceutical Research
  • 2019
TLDR
CB2R is considered as a novel target for the development of pharmacological approaches in the treatment of various illnesses, as cancer and neurodegenerative diseases.
Advances in Neurobiology and Pharmacology of GPR12
TLDR
This review analyzes all the direct available information in PubMed database about expression, function, and pharmacology of this receptor in central nervous system (CNS) trying to provide a broad overview of its current and prospective neurophysiology.
Endocannabinoid system and mood disorders: priming a target for new therapies.
β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.
TLDR
This review of the literature suggests that the development of opioid and cannabinoid agonists that bias MOR and CB1R toward G protein signaling cascades and away from β-arrestin interactions may provide a novel mechanism by which to produce analgesia with less severe adverse effects.
...
...

References

SHOWING 1-10 OF 232 REFERENCES
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
  • R. Pertwee
  • Biology, Chemistry
    Expert opinion on investigational drugs
  • 2000
This review highlights some important advances that have taken place in cannabinoid research over the last four years. It focuses on novel ligands that are of interest either as experimental tools or
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
The endocannabinoid nervous system: unique opportunities for therapeutic intervention.
Pharmacology of cannabinoid receptor ligands.
  • R. Pertwee
  • Biology, Chemistry
    Current medicinal chemistry
  • 1999
TLDR
This review summarizes current knowledge about the in vitro pharmacological properties of important CB1 and CB2 receptor ligands and pays particular attention to the binding properties of these ligands, to the efficacies of cannabinoid receptor agonists, as determined using cyclic AMP or [35S]GTPgammaS binding assays, and to selected examples of how these pharmacological Properties can be influenced by chemical structure.
Cannabinoid receptors and pain
  • R. Pertwee
  • Biology, Chemistry
    Progress in Neurobiology
  • 2001
Discovery and characterization of endogenous cannabinoids.
The endocannabinoid signaling system: Pharmacological and therapeutic aspects
CB2 receptor ligands.
  • J. Huffman
  • Chemistry, Biology
    Mini reviews in medicinal chemistry
  • 2005
TLDR
Several derivatives of traditional dibenzopyran based cannabinoids have also been found to have significant selectivity for the CB(2) receptor, and 1-deoxy-3-(1',1'-dimethylbutyl)-Delta(8)-THC (JWH-133) shows two hundred-fold selectivity in comparison to many cannabinoid receptor ligands.
...
...